{"title":"COPD加重与合并症、肺功能和死亡率的相关性在英国单一实践初级保健队列中","authors":"Mukesh Singh, Ketan Singh","doi":"10.1183/13993003.congress-2019.pa5010","DOIUrl":null,"url":null,"abstract":"Introduction and Objectives: COPD as being a heterogeneous disease, its patients show variation in disease severity, burden of comorbidity and their need for unscheduled clinical consultations. The aim of this retrospective study was to evaluate patterns in clinical care and COPD related ‘events’ across a single-year in a UK single-practice primary-care cohort. Methods: The clinical record system of practice population of 11474 patients was searched to identify all registered patients with COPD with data available for the period April17–March18. All cases were reviewed including disease duration, account of exacerbations with their treatment, related hospitalizations and mortality, co-morbidities and changes in FEV1. Results: Out of total 331 COPD patients; most had long-standing disease approx 10 years, although this varied widely. Mean % FEV1 was 60.4% (range 14–118%) with 71% with dyspnoea of MRC 2 or 3. 95% of them had at least one co-morbidity, mainly diabetes/arthritis or cardiovascular disease. There was no exacerbation in 137 patients (41.4%). Of patients with at least one event, 111 (33.5%) required treatment with antibiotics + oral steroids and 28 of these patients (8.5%) showed decline in FEV1. 22 patients required emergency COPD-related hospitalisations with 5 in-hospital deaths. The mean FEV1 in those patients without an exacerbation was higher compared to those with an exacerbation (66.6% vs 55.9%) and a further decline was noted in those with hospital admission history (45.8%). Conclusions: A substantial variation was observed in COPD disease burden and healthcare resource usage within the 12 months across a primary-care cohort in UK.","PeriodicalId":432006,"journal":{"name":"General practice and primary care","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK\",\"authors\":\"Mukesh Singh, Ketan Singh\",\"doi\":\"10.1183/13993003.congress-2019.pa5010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction and Objectives: COPD as being a heterogeneous disease, its patients show variation in disease severity, burden of comorbidity and their need for unscheduled clinical consultations. The aim of this retrospective study was to evaluate patterns in clinical care and COPD related ‘events’ across a single-year in a UK single-practice primary-care cohort. Methods: The clinical record system of practice population of 11474 patients was searched to identify all registered patients with COPD with data available for the period April17–March18. All cases were reviewed including disease duration, account of exacerbations with their treatment, related hospitalizations and mortality, co-morbidities and changes in FEV1. Results: Out of total 331 COPD patients; most had long-standing disease approx 10 years, although this varied widely. Mean % FEV1 was 60.4% (range 14–118%) with 71% with dyspnoea of MRC 2 or 3. 95% of them had at least one co-morbidity, mainly diabetes/arthritis or cardiovascular disease. There was no exacerbation in 137 patients (41.4%). Of patients with at least one event, 111 (33.5%) required treatment with antibiotics + oral steroids and 28 of these patients (8.5%) showed decline in FEV1. 22 patients required emergency COPD-related hospitalisations with 5 in-hospital deaths. The mean FEV1 in those patients without an exacerbation was higher compared to those with an exacerbation (66.6% vs 55.9%) and a further decline was noted in those with hospital admission history (45.8%). Conclusions: A substantial variation was observed in COPD disease burden and healthcare resource usage within the 12 months across a primary-care cohort in UK.\",\"PeriodicalId\":432006,\"journal\":{\"name\":\"General practice and primary care\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"General practice and primary care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1183/13993003.congress-2019.pa5010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"General practice and primary care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa5010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
前言和目的:慢性阻塞性肺病是一种异质性疾病,其患者在疾病严重程度、合并症负担和非预定临床会诊需求方面存在差异。本回顾性研究的目的是评估英国单一诊所初级保健队列中一年中临床护理和COPD相关“事件”的模式。方法:检索实践人群11474例COPD患者的临床记录系统,以确定所有登记的COPD患者在4月17日至3月18日期间的数据。对所有病例进行回顾,包括病程、治疗后病情加重的情况、相关住院和死亡率、合并症和FEV1的变化。结果:331例COPD患者中;大多数人都有大约10年的长期疾病,尽管这种情况差别很大。平均FEV1 %为60.4%(范围14-118%),其中71%为MRC 2或3级呼吸困难。95%的患者至少有一种合并症,主要是糖尿病/关节炎或心血管疾病。137例(41.4%)患者无加重。在至少发生一次事件的患者中,111例(33.5%)需要抗生素+口服类固醇治疗,其中28例(8.5%)出现FEV1下降。22名患者需要与copd相关的紧急住院治疗,其中5人在院内死亡。无急性加重患者的平均FEV1高于有急性加重患者(66.6% vs 55.9%),有住院史患者的平均FEV1进一步下降(45.8%)。结论:在英国的一个初级保健队列中,在12个月内观察到COPD疾病负担和医疗资源使用的实质性变化。
Corerelation of COPD exacerbation with comorbidities, Lung function and mortality within a single-practice primary-care cohort in the UK
Introduction and Objectives: COPD as being a heterogeneous disease, its patients show variation in disease severity, burden of comorbidity and their need for unscheduled clinical consultations. The aim of this retrospective study was to evaluate patterns in clinical care and COPD related ‘events’ across a single-year in a UK single-practice primary-care cohort. Methods: The clinical record system of practice population of 11474 patients was searched to identify all registered patients with COPD with data available for the period April17–March18. All cases were reviewed including disease duration, account of exacerbations with their treatment, related hospitalizations and mortality, co-morbidities and changes in FEV1. Results: Out of total 331 COPD patients; most had long-standing disease approx 10 years, although this varied widely. Mean % FEV1 was 60.4% (range 14–118%) with 71% with dyspnoea of MRC 2 or 3. 95% of them had at least one co-morbidity, mainly diabetes/arthritis or cardiovascular disease. There was no exacerbation in 137 patients (41.4%). Of patients with at least one event, 111 (33.5%) required treatment with antibiotics + oral steroids and 28 of these patients (8.5%) showed decline in FEV1. 22 patients required emergency COPD-related hospitalisations with 5 in-hospital deaths. The mean FEV1 in those patients without an exacerbation was higher compared to those with an exacerbation (66.6% vs 55.9%) and a further decline was noted in those with hospital admission history (45.8%). Conclusions: A substantial variation was observed in COPD disease burden and healthcare resource usage within the 12 months across a primary-care cohort in UK.